CVS Health Corporation (NYSE: CVS)

• Support level
  $70.04
• Resistance level
  N/A

• Beta
  0.7
• RSI (14-day)
  84.7

• CVS is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
• CVS is one of this month's top performers with a return of 16.0 percent, beating 90 percent of stocks in the S&P-100.
• Up 2.3 percent, CVS is one of this week's biggest gainers.
• Volatility is forecast to fall over the next month.
• With RSI > 70, CVS is overbought. Odds slightly favor a short-term price reversal.
• Price broke above prior resistance level - a short-term bullish signal.

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

• In the next week
  7.6%
• In the next month
  16.4%
• In the next year
  71.4%